Understanding MCP‐MOD dose finding as a method based on linear regression

MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated wi...

Full description

Saved in:
Bibliographic Details
Published inStatistics in medicine Vol. 36; no. 27; pp. 4401 - 4413
Main Author Thomas, Neal
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 30.11.2017
Subjects
Online AccessGet full text
ISSN0277-6715
1097-0258
1097-0258
DOI10.1002/sim.7424

Cover

Abstract MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of “good” candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP‐MOD procedure can be alternatively represented as a method based on simple linear regression, where “simple” refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness‐of‐fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data‐based model selection.
AbstractList MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple-comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of "good" candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP-MOD procedure can be alternatively represented as a method based on simple linear regression, where "simple" refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness-of-fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data-based model selection.
MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of “good” candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP‐MOD procedure can be alternatively represented as a method based on simple linear regression, where “simple” refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness‐of‐fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data‐based model selection.
MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of “good” candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP‐MOD procedure can be alternatively represented as a method based on simple linear regression, where “simple” refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness‐of‐fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data‐based model selection.
MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple-comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of "good" candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP-MOD procedure can be alternatively represented as a method based on simple linear regression, where "simple" refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness-of-fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data-based model selection.MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple-comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of "good" candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP-MOD procedure can be alternatively represented as a method based on simple linear regression, where "simple" refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness-of-fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data-based model selection.
Author Thomas, Neal
Author_xml – sequence: 1
  givenname: Neal
  orcidid: 0000-0002-1915-8487
  surname: Thomas
  fullname: Thomas, Neal
  email: snthomas99@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28879676$$D View this record in MEDLINE/PubMed
BookMark eNp10c1O3DAQB3ALUZWFVuIJkCUuvWQ7dmJPckRLP1BZUanlbDnJGIwSG-ysKm59hD5jn6ShC0Wq2tNI1s-jmfnvs90QAzF2KGApAOTb7MclVrLaYQsBDRYgVb3LFiARC41C7bH9nG8AhFASX7I9WdfYaNQL9uky9JTyZEPvwxVfrz7__P5jfXHK-5iJO799tplbPtJ0HXve2kw9j4EPPpBNPNFVopx9DK_YC2eHTK8f6wG7fP_u6-pjcX7x4Wx1cl50ZdVUhSJrsVGlK7EnVbWdQGpqp6HusENUAI11ogdXt1WlGgWyk-BaqpGgdALKA_Zm2_c2xbsN5cmMPnc0DDZQ3GQjmlJrKTVWMz3-i97ETQrzdLPSgFqC1rM6elSbdqTe3CY_2nRvns40g-UWdCnmnMiZzk92mneekvWDEWAecjBzDuYhh-cR_3x46vkPWmzpNz_Q_X-d-XK2_u1_AQw6lMs
CitedBy_id crossref_primary_10_1002_sim_8444
crossref_primary_10_1111_biom_13442
crossref_primary_10_1002_pst_2428
crossref_primary_10_1016_j_cct_2022_106957
crossref_primary_10_1136_bmjopen_2023_079158
crossref_primary_10_1002_bimj_202100044
Cites_doi 10.1177/0049124104268644
10.1111/biom.12563
10.1080/19466315.2014.924876
10.1007/978-1-4757-3294-8
10.1080/10543400600860428
10.1080/19466315.2016.1256229
10.1111/biom.12357
10.1111/j.1541-0420.2005.00344.x
10.1002/sim.6052
10.1002/9781118625590
10.1002/pst.1693
10.1007/978-3-642-01689-9
10.1080/10543400600860469
10.1017/CBO9780511546822
10.2307/2529336
10.1002/bimj.4710270104
ContentType Journal Article
Copyright Copyright © 2017 John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2017 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1002/sim.7424
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)

CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Statistics
Public Health
EISSN 1097-0258
EndPage 4413
ExternalDocumentID 28879676
10_1002_sim_7424
SIM7424
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABOCM
ABPVW
ACAHQ
ACCFJ
ACCZN
ACGFS
ACPOU
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
SV3
TN5
UB1
V2E
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WUP
WWH
WXSBR
WYISQ
XBAML
XG1
XV2
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
AMVHM
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c3494-5eaa7953f37de54bc17e98f608c7c775009af1d0f8b4459502c20fbe87e03f103
IEDL.DBID DR2
ISSN 0277-6715
1097-0258
IngestDate Thu Jul 10 19:19:02 EDT 2025
Tue Oct 07 05:51:23 EDT 2025
Wed Feb 19 02:40:42 EST 2025
Wed Oct 01 04:09:03 EDT 2025
Thu Apr 24 23:03:37 EDT 2025
Wed Jan 22 16:21:25 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 27
Keywords emax
weighted least squares (WLS) regression
dose response
MCP-MOD
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
Copyright © 2017 John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3494-5eaa7953f37de54bc17e98f608c7c775009af1d0f8b4459502c20fbe87e03f103
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1915-8487
PMID 28879676
PQID 1960762066
PQPubID 48361
PageCount 13
ParticipantIDs proquest_miscellaneous_1936622674
proquest_journals_1960762066
pubmed_primary_28879676
crossref_citationtrail_10_1002_sim_7424
crossref_primary_10_1002_sim_7424
wiley_primary_10_1002_sim_7424_SIM7424
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 30 November 2017
PublicationDateYYYYMMDD 2017-11-30
PublicationDate_xml – month: 11
  year: 2017
  text: 30 November 2017
  day: 30
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Statistics in medicine
PublicationTitleAlternate Stat Med
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2017; 73
1976; 32
2004; 33
2015; 14
2015; 71
2000
2006; 16
2017; 35
2009
1998
1977; 4
2006
2016
2015
2005; 61
2002
2014; 6
2014; 33
1985; 27
1988
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
Cox D (e_1_2_7_17_1) 1977; 4
e_1_2_7_19_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_25_1
e_1_2_7_13_1
Robertson T (e_1_2_7_23_1) 1988
e_1_2_7_24_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_22_1
e_1_2_7_10_1
Burnham K (e_1_2_7_18_1) 2002
e_1_2_7_21_1
e_1_2_7_20_1
References_xml – year: 2009
– volume: 6
  start-page: 302
  issue: 4
  year: 2014
  end-page: 317
  article-title: Meta‐analysis of clinical dose‐response in a large drug development portfolio
  publication-title: Stat Biopharma Res
– year: 2002
– volume: 32
  start-page: 1
  year: 1976
  end-page: 49
  article-title: The analysis and selection of variables in linear regression
  publication-title: Biometrics
– volume: 35
  start-page: 137
  issue: 17
  year: 2017
  end-page: 146
  article-title: Analysis of clinical dose‐response in small‐molecule drug development: 2009‐2014
  publication-title: Statistics in Biopharmaceutical Research
– year: 1988
– volume: 16
  start-page: 639
  year: 2006
  end-page: 656
  article-title: Design and analysis of dose finding studies combining multiple comparisons and modeling procedures
  publication-title: J Biopharm Stat
– year: 2006
– volume: 71
  start-page: 996
  year: 2015
  end-page: 1008
  article-title: Dose response signal detection under model uncertainty
  publication-title: Biometrics
– volume: 14
  start-page: 359
  year: 2015
  end-page: 367
  article-title: Characterization of dose‐response for count data using a generalized MCP‐Mod approach in an adaptive dose‐ranging trial
  publication-title: Pharma Stat
– year: 2000
– volume: 33
  start-page: 261
  year: 2004
  end-page: 304
  article-title: Multimodel inference: understanding AIC and BIC in model selection
  publication-title: Socio Methods Res
– volume: 33
  start-page: 1646
  year: 2014
  end-page: 1661
  article-title: Model‐based dose finding under model uncertainty using general parametric models
  publication-title: Stat Med
– volume: 61
  start-page: 738
  year: 2005
  end-page: 748
  article-title: Combining multiple comparisons and modeling techniques in dose‐response studies
  publication-title: Biometrics
– volume: 16
  start-page: 657
  year: 2006
  end-page: 677
  article-title: Hypothesis testing and Bayesian estimation using a sigmoid model applied to sparse dose‐response designs
  publication-title: J Biopharma Stat
– volume: 73
  start-page: 197
  issue: 1
  year: 2017
  end-page: 205
  article-title: Likelihood ratio tests for a dose‐response effect using multiple nonlinear regression models
  publication-title: Biometrics
– volume: 4
  start-page: 49
  year: 1977
  end-page: 70
  article-title: The role of significance tests
  publication-title: Scand J Stat
– year: 2016
– volume: 27
  start-page: 25
  year: 1985
  end-page: 38
  article-title: The application of Hunter's inequality in simultaneous testing
  publication-title: Biom J
– year: 2015
– year: 1998
– ident: e_1_2_7_19_1
  doi: 10.1177/0049124104268644
– ident: e_1_2_7_5_1
  doi: 10.1111/biom.12563
– ident: e_1_2_7_13_1
  doi: 10.1080/19466315.2014.924876
– ident: e_1_2_7_2_1
– ident: e_1_2_7_16_1
  doi: 10.1007/978-1-4757-3294-8
– ident: e_1_2_7_6_1
  doi: 10.1080/10543400600860428
– ident: e_1_2_7_21_1
  doi: 10.1080/19466315.2016.1256229
– ident: e_1_2_7_4_1
  doi: 10.1111/biom.12357
– ident: e_1_2_7_14_1
– volume: 4
  start-page: 49
  year: 1977
  ident: e_1_2_7_17_1
  article-title: The role of significance tests
  publication-title: Scand J Stat
– ident: e_1_2_7_11_1
– ident: e_1_2_7_3_1
  doi: 10.1111/j.1541-0420.2005.00344.x
– ident: e_1_2_7_7_1
  doi: 10.1002/sim.6052
– ident: e_1_2_7_25_1
  doi: 10.1002/9781118625590
– ident: e_1_2_7_8_1
  doi: 10.1002/pst.1693
– ident: e_1_2_7_10_1
  doi: 10.1007/978-3-642-01689-9
– ident: e_1_2_7_12_1
  doi: 10.1080/10543400600860469
– ident: e_1_2_7_9_1
– ident: e_1_2_7_24_1
  doi: 10.1017/CBO9780511546822
– volume-title: Model Selection and Multimodel Inference: A Practical Information‐Theoretic Approach
  year: 2002
  ident: e_1_2_7_18_1
– volume-title: Order Restricted Statistical Inference
  year: 1988
  ident: e_1_2_7_23_1
– ident: e_1_2_7_20_1
  doi: 10.2307/2529336
– ident: e_1_2_7_15_1
– ident: e_1_2_7_22_1
  doi: 10.1002/bimj.4710270104
SSID ssj0011527
Score 2.26537
Snippet MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate...
MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4401
SubjectTerms dose response
Dose-Response Relationship, Drug
Drug dosages
emax
Humans
Linear Models
MCP‐MOD
Medical statistics
Models, Statistical
Pharmaceutical Preparations - administration & dosage
Regression analysis
weighted least squares (WLS) regression
Title Understanding MCP‐MOD dose finding as a method based on linear regression
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.7424
https://www.ncbi.nlm.nih.gov/pubmed/28879676
https://www.proquest.com/docview/1960762066
https://www.proquest.com/docview/1936622674
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Mathematics Source
  customDbUrl:
  eissn: 1097-0258
  dateEnd: 20241105
  omitProxy: false
  ssIdentifier: ssj0011527
  issn: 0277-6715
  databaseCode: AMVHM
  dateStart: 20120220
  isFulltext: true
  titleUrlDefault: https://www.ebsco.com/products/research-databases/mathematics-source
  providerName: EBSCOhost
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0277-6715
  databaseCode: DR2
  dateStart: 19960101
  customDbUrl:
  isFulltext: true
  eissn: 1097-0258
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011527
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6hHlAlVGBL24VSGakqp2wdJ7aTY1VYLaC0FbBSJQ6RE9sVos2ize6FE4_AM_IkHcdJ-gOVqp4iJRPH8XjGnz32NwC7luuUK6sDa4wIYsXTIOW0DJhWTFiFAN-6iG52JCbT-OMpP213VbqzMJ4fol9wc5bR-Gtn4Kqo969IQ-vvFyOc1zkq0DASzWzqc88cFXbZWl2EUsiQd7yzlO13L94cif6BlzfRajPcjJ_Ct66ifpfJj9FyUYzKX7c4HB_2J89grUWh5MB3m-fwyFQDeJy1cfYBPPGrecQfUhrAqsOkntJ5HT5Nrx-IIdnhyd_ff7Ljd0TPakOaIDjeVjVRxOenJm6o1GRWEVdXNSdzc-a331YvYDp-__VwErQ5GYLSEdkE3CglUx7ZSGrD46IMpUF9CpqUspQIP2iqbKipTYo45qh2VjJqC5NIQyMb0mgDVqpZZbaAJJwJSTVNjNDoroVikoaJsJaxIlaGD-Ftp5-8bAnLXd6M89xTLbMcGy53DTeEN73kT0_S8R-Z7U7FeWumdY7uh-JogLALi-gfo4G5qImqzGzpZCIhEKRKLGLTd43-IwxddIpVH8Jeo-A7v55_-ZC568v7Cr6CVeYAREMyuQ0ri_nSvEb4syh2mo5-Cez0AAM
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9UwFD9BTJCEoFxRr6LWxMDTLl23tlt4Mii5CEOj3IQHkqVbW2PUXXL_vPDER_Az8kk4XbcB_kmMT0u2s67r6Tn9taf9HYDXluuUK6sDa4wIYsXTIOW0DJhWTFiFAN-6iG52JIaj-P0JP1mAnfYsjOeH6BbcnGXU_toZuFuQ3r5mDZ1-_THAiV18B-7GAqcpDhF96rijwjZfq4tRChnylnmWsu32zdtj0W8A8zZerQecvftw2lbV7zP5NpjPikF5_guL43_-ywNYbYAoeeN7zhosmKoHS1kTau_Bil_QI_6cUg-WHSz1rM4P4WB080wMyXY_Xl78zD68JXo8NaSOg-NtNSWK-BTVxI2Wmowr4iqrJmRivvgduNU6jPbeHe8OgyYtQ1A6LpuAG6VkyiMbSW14XJShNKhSQZNSlhIRCE2VDTW1SRHHHDXPSkZtYRJpaGRDGj2CxWpcmSdAEs6EpJomRmj02EIxScNEWMtYESvD-7DVKigvG85ylzrje-7ZllmODZe7huvDq07yzPN0_EFmo9Vx3ljqNEcPRHFAQOSFRXSP0cZc4ERVZjx3MpEQiFMlFvHY943uIwy9dIpV78NmreG_fj3_vJ-569N_FXwJ94bH2WF-uH908AyWmcMTNefkBizOJnPzHNHQrHhR9_or-C0EJA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VVqoqoQILLVsKGAnRU7aOE9uJOKFuVy0lpSpdqYdKkRPbCEGz1f5ceuIReEaehHGcBEpBQpwiJRPb8XjGXzz2NwAvLdcpV1YH1hgRxIqnQcppGTCtmLAKAb51Ed3sWByM47fn_HwJXrdnYTw_RLfg5iyj9tfOwM2Vtrs_WUNnny4H-GMX34GVmKeJ2883PO24o8I2X6uLUQoZ8pZ5lrLd9s2bc9EtgHkTr9YTzugeXLRN9ftMPg8W82JQXv_G4vif33If1hsgSt74kfMAlkzVg9WsCbX34K5f0CP-nFIP1hws9azOD-Fo_OuZGJLtnXz_-i17PyR6MjOkjoPjbTUjivgU1cTNlppMKuIaq6Zkaj76HbjVIxiP9s_2DoImLUNQOi6bgBulZMojG0lteFyUoTSoUkGTUpYSEQhNlQ01tUkRo2I4ZSWjtjCJNDSyIY02YLmaVOYxkIQzIammiREaPbZQTNIwEdYyVsTK8D7stArKy4az3KXO-JJ7tmWWY8flruP68KKTvPI8HX-Q2W51nDeWOsvRA1GcEBB5YRHdY7QxFzhRlZksnEwkBOJUiUVs-rHRVcLQS6fY9D68qjX819rzD4eZu279q-BzWD0ZjvJ3h8dHT2CNOThRU05uw_J8ujBPEQzNi2f1oP8BmpYDqA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Understanding+MCP%E2%80%90MOD+dose+finding+as+a+method+based+on+linear+regression&rft.jtitle=Statistics+in+medicine&rft.au=Thomas%2C+Neal&rft.date=2017-11-30&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=36&rft.issue=27&rft.spage=4401&rft.epage=4413&rft_id=info:doi/10.1002%2Fsim.7424&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_sim_7424
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon